Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04656210

Myotonic Dystrophy - Vascular and Cognition

Links Between Diabetes and Cognitive Impairment in Myotonic Dystrophy Type 1 : a Non-conventional MRI Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The cognitive disorders of adult forms of myotonic dystrophies type 1 are heterogeneous (impairment of executive functions, visio construction and theory of the mind, which can progress to the stage of dementia). Nevertheless, patients have very different degrees of cognitive impairment. Expansion of CTG triplets disrupts the alternative splicing of mRNAs of various proteins, including the insulin receptor and Tau protein. Type 2 diabetes, associated with peripheral insulin resistance, is therefore common in this pathology. Type 2 diabetes,could to explain the cognitive impairment of patients, through the accelerated development of brain lesions (especially tauopathy and cerebral atrophy).

Conditions

Interventions

TypeNameDescription
RADIATIONMRINon conventional MRI (35 minutes)
OTHERneuropsychological testsStandardized and quantified neuropsychological assessment

Timeline

Start date
2021-10-14
Primary completion
2024-10-13
Completion
2029-01-01
First posted
2020-12-07
Last updated
2025-05-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04656210. Inclusion in this directory is not an endorsement.